Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Shares Outstanding (2016 - 2025)

Milestone Scientific's Shares Outstanding history spans 16 years, with the latest figure at $78.6 million for Q2 2025.

  • For Q2 2025, Shares Outstanding rose 1.77% year-over-year to $78.6 million; the TTM value through Jun 2025 reached $78.6 million, up 1.77%, while the annual FY2024 figure was $78.0 million, 2.85% up from the prior year.
  • Shares Outstanding for Q2 2025 was $78.6 million at Milestone Scientific, roughly flat from $78.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $78.6 million in Q2 2025 and bottomed at $66.6 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $70.0 million (2023), against an average of $72.1 million.
  • The largest annual shift saw Shares Outstanding soared 33.47% in 2021 before it grew 1.69% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $68.2 million in 2021, then rose by 1.69% to $69.3 million in 2022, then increased by 9.49% to $75.9 million in 2023, then increased by 2.85% to $78.0 million in 2024, then grew by 0.7% to $78.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Shares Outstanding are $78.6 million (Q2 2025), $78.2 million (Q1 2025), and $78.0 million (Q4 2024).